The UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR). National Eczema Society attends twice-yearly A-STAR Study Steering Committee meetings as a patient representative. The purpose of A-STAR is to collect information from adult and paediatric patients with eczema starting certain treatments, such as ciclosporin, methotrexate, azathioprine, or novel treatments, such as biologics and so-called ‘small molecules’. The study aims to establish how well these medicines work with regard to improvement in disease severity, quality of life and also safety, especially when these medicines are used for longer periods of time.